Balance Sheet Data
Nymox Pharmaceutical Corporation (NYMX)
$0.1999
-0.00 (-0.05%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 7.95 | 5.24 | 3.61 | 0.83 | 1.40 | 0.08 | 0.02 | 0 | 0 | 0 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.04 | 0.02 | 0.03 | 0.03 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Inventories (%) | ||||||||||
| Accounts Payable | 0.81 | 1.63 | 1.40 | 1.27 | 1.70 | 0.09 | 0.02 | 0 | 0 | 0 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.04 | -0.01 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.